Streetwise Articles

Mining Company Updates PEA for Ontario Project
Source: Streetwise Reports(10/20/19)
This is a step forward as the firm continues to advance and derisk the project. More >

Michael Ballanger

Q4 Guesstimates: Precious Metals, Miners and Stocks
Source: Michael Ballanger for Streetwise Reports(10/20/19)
Sector expert Michael Ballanger reflects on modern monetary policy and discusses his most recent investment decisions. More >

Canadian Gold Miner Delivers 'Strong Quarter,' Raises Guidance
Source: Streetwise Reports(10/18/19)
The production numbers are reviewed in a BMO Capital Markets report. More >

John Newell

Explorer in Canada's Red Lake District Moves Ahead with Three Projects
Source: John Newell for Streetwise Reports(10/18/19)
John Newell of Fieldhouse Capital Management explores the investment opportunities presented by this project generator in a district rich with historic mine strikes. More >

Dermira's Phase 2b Atopic Dermatitis Trial Results Send Shares 25% Higher
Source: Streetwise Reports(10/18/19)
Dermira shares traded higher today after the firm released positive data from its phase 2b study of lebrikizumab in patients with atopic dermatitis at the Las Vegas Fall Clinical Dermatology Conference. More >

Seplat Petroleum to Acquire Eland Oil & Gas
Source: Streetwise Reports(10/17/19)
A glance at the deal is provided in a Pareto Securities report. More >

Protalix Shares Trade up 70% Upon Release of Phase 3 Fabry Disease Data
Source: Streetwise Reports(10/17/19)
Shares of Protalix Biotherapeutics skyrocketed today on much higher than average volume as the firm announced positive 12-month interim data from its BRIDGE Phase 3 open label switch-over study of pegunigalsidase alfa (PRX-102) for the treatment of Fabry disease. More >

University of Wisconsin Police to Beta Test Concealed Weapons Solution
Source: Streetwise Reports(10/17/19)
This marks the product developer's entry into a new segment of the public venues market. More >

Uranium Firm Comments on Nuclear Fuel Working Group Extension
Source: Streetwise Reports(10/17/19)
The company expects action by President Trump following the nuclear fuel working group's recommendations. More >

Energy Company 'Shaking Things Up With Royalty, Infrastructure Spinout'
Source: Streetwise Reports(10/16/19)
The transaction details are relayed in a CIBC report. More >

Explorer Extends Gold Mineralization at Great Basin Project
Source: Streetwise Reports(10/16/19)
Drilling is about to start at one of the company's projects and continues at the other two. More >

Explorer Connects Two Deposits at Ontario Project, Aims to Link Third
Source: Streetwise Reports(10/16/19)
Accordingly, the company continues an expanded, aggressive stepout drill program there. More >

Healthcare Tech Firm Signs Five New Clients in Texas
Source: Streetwise Reports(10/16/19)
The company just landed another five clients in Texas and now plans to build out sales teams in five additional states. More >

Pan Orient Energy: The New Orient Express
Source: Chen Lin for Streetwise Reports(10/16/19)
Veteran investor and newsletter writer Chen Lin explains the upside he sees with this energy company. More >

Achillion Pharma Shares Open 75% Higher After Alexion Buyout Offer
Source: Streetwise Reports(10/16/19)
Shares of Achillion Pharmaceuticals are trading much higher today after the firm reported that it has agreed to be acquired by Alexion Pharmaceuticals for $930 million, or $6.30 per share in cash, along with the potential for an additional $2 per share if certain other specific clinical trial and regulatory milestones are met. More >

U.S. Uranium Company Shortens Time Required to Production at Mines
Source: Streetwise Reports(10/16/19)
It did this through capital improvements at each of its various facilities. More >

Resource Company to Acquire Mineral Concession in Mexico
Source: Streetwise Reports(10/16/19)
The purchase expands the holdings of its principal project there. More >

Assembly Biosciences Stock Sizzles Following Phase 2a Announcement and Buy Rating from Mizuho
Source: Streetwise Reports(10/16/19)
Good news is piling up for this healthcare stock engaged in the treatment of hepatitis B as it trades at 5X its average volume with a 30% stock price gain over previous close. More >

Maurice Jackson

Skyharbour Drilling Deeper in Athabasca Basin
Source: Maurice Jackson for Streetwise Reports(10/16/19)
Jordan Trimble, CEO of Skyharbour Resources, sits down with Maurice Jackson of Proven and Probable to discuss his company's exploration plans in Canada's uranium-rich Athabasca Basin. More >

Platinum Group Metal Cowboys in Montana
Source: Streetwise Reports(10/15/19)
A small-cap company in Montana is exploring to find out if its property contains "Platreef-style" PGE mineralization. More >

Healthcare Company to Use IBM's Watson AI in Telemedicine App
Source: Streetwise Reports(10/15/19)
The goal is to reduce the time healthcare workers spend on mundane tasks and thereby improve patient care. More >

Relmada Therapeutics Stock Soars on Phase 2 Depression Study Results
Source: Streetwise Reports(10/15/19)
Shares of Relmada Therapeutics have traded wildly today after it announced Phase 2 results for its anti-depressant drug dextromethadone. The firm's shares have traded 100200% higher today and the stock was halted several times trading due to extreme price volatility. More >

Drill Results from Nevada Project Show Resource Expansion Potential
Source: Streetwise Reports(10/14/19)
The company will use these new data in designing the mine and optimizing the prefeasibility study. More >

Target Raised on Gold Miner 'On Track to Meet Overall Guidance'
Source: Streetwise Reports(10/14/19)
Q3/19 production totals from the company's various assets are discussed in a CIBC report. More >

Technical Analyst Expects Health Technologies Firm to Break Higher
Source: Clive Maund for Streetwise Reports(10/14/19)
Technical analyst Clive Maund outlines the reasons this stock might break higher. More >

Showing Results: 1 to 25 of 17371 Next

Notable Quotes

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe